Pneumococcal Vaccines-India Market Status and Trend Report 2013-2023
Report Summary
Pneumococcal Vaccines-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pneumococcal Vaccines industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole India and Regional Market Size of Pneumococcal Vaccines 2013-2017, and development forecast 2018-2023
Main market players of Pneumococcal Vaccines in India, with company and product introduction, position in the Pneumococcal Vaccines market
Market status and development trend of Pneumococcal Vaccines by types and applications
Cost and profit status of Pneumococcal Vaccines, and marketing status
Market growth drivers and challenges
The report segments the India Pneumococcal Vaccines market as:
India Pneumococcal Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North India
Northeast India
East India
South India
West India
India Pneumococcal Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
PPSV 23
PCV 7/13
PCV 10
India Pneumococcal Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
For Infants
For Children (2-10)
For Person (10-64)
For The Old (?65)
India Pneumococcal Vaccines Market: Players Segment Analysis (Company and Product introduction, Pneumococcal Vaccines Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pneumococcal Vaccines-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pneumococcal Vaccines industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole India and Regional Market Size of Pneumococcal Vaccines 2013-2017, and development forecast 2018-2023
Main market players of Pneumococcal Vaccines in India, with company and product introduction, position in the Pneumococcal Vaccines market
Market status and development trend of Pneumococcal Vaccines by types and applications
Cost and profit status of Pneumococcal Vaccines, and marketing status
Market growth drivers and challenges
The report segments the India Pneumococcal Vaccines market as:
India Pneumococcal Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North India
Northeast India
East India
South India
West India
India Pneumococcal Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
PPSV 23
PCV 7/13
PCV 10
India Pneumococcal Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
For Infants
For Children (2-10)
For Person (10-64)
For The Old (?65)
India Pneumococcal Vaccines Market: Players Segment Analysis (Company and Product introduction, Pneumococcal Vaccines Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PNEUMOCOCCAL VACCINES
1.1 Definition of Pneumococcal Vaccines in This Report
1.2 Commercial Types of Pneumococcal Vaccines
1.2.1 PPSV
1.2.2 PCV 7/13
1.2.3 PCV
1.3 Downstream Application of Pneumococcal Vaccines
1.3.1 For Infants
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (?65)
1.4 Development History of Pneumococcal Vaccines
1.5 Market Status and Trend of Pneumococcal Vaccines 2013-2023
1.5.1 India Pneumococcal Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Pneumococcal Vaccines Market Status and Trend 2013-2023
CHAPTER 2 INDIA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pneumococcal Vaccines in India 2013-2017
2.2 Consumption Market of Pneumococcal Vaccines in India by Regions
2.2.1 Consumption Volume of Pneumococcal Vaccines in India by Regions
2.2.2 Revenue of Pneumococcal Vaccines in India by Regions
2.3 Market Analysis of Pneumococcal Vaccines in India by Regions
2.3.1 Market Analysis of Pneumococcal Vaccines in North India 2013-2017
2.3.2 Market Analysis of Pneumococcal Vaccines in Northeast India 2013-2017
2.3.3 Market Analysis of Pneumococcal Vaccines in East India 2013-2017
2.3.4 Market Analysis of Pneumococcal Vaccines in South India 2013-2017
2.3.5 Market Analysis of Pneumococcal Vaccines in West India 2013-2017
2.4 Market Development Forecast of Pneumococcal Vaccines in India 2017-2023
2.4.1 Market Development Forecast of Pneumococcal Vaccines in India 2017-2023
2.4.2 Market Development Forecast of Pneumococcal Vaccines by Regions 2017-2023
CHAPTER 3 INDIA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole India Market Status by Types
3.1.1 Consumption Volume of Pneumococcal Vaccines in India by Types
3.1.2 Revenue of Pneumococcal Vaccines in India by Types
3.2 India Market Status by Types in Major Countries
3.2.1 Market Status by Types in North India
3.2.2 Market Status by Types in Northeast India
3.2.3 Market Status by Types in East India
3.2.4 Market Status by Types in South India
3.2.5 Market Status by Types in West India
3.3 Market Forecast of Pneumococcal Vaccines in India by Types
CHAPTER 4 INDIA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pneumococcal Vaccines in India by Downstream Industry
4.2 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pneumococcal Vaccines by Downstream Industry in North India
4.2.2 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Northeast India
4.2.3 Demand Volume of Pneumococcal Vaccines by Downstream Industry in East India
4.2.4 Demand Volume of Pneumococcal Vaccines by Downstream Industry in South India
4.2.5 Demand Volume of Pneumococcal Vaccines by Downstream Industry in West India
4.3 Market Forecast of Pneumococcal Vaccines in India by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PNEUMOCOCCAL VACCINES
5.1 India Economy Situation and Trend Overview
5.2 Pneumococcal Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 6 PNEUMOCOCCAL VACCINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN INDIA
6.1 Sales Volume of Pneumococcal Vaccines in India by Major Players
6.2 Revenue of Pneumococcal Vaccines in India by Major Players
6.3 Basic Information of Pneumococcal Vaccines by Major Players
6.3.1 Headquarters Location and Established Time of Pneumococcal Vaccines Major Players
6.3.2 Employees and Revenue Level of Pneumococcal Vaccines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PNEUMOCOCCAL VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pfizer
7.1.1 Company profile
7.1.2 Representative Pneumococcal Vaccines Product
7.1.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Pfizer
7.2 Sanofi
7.2.1 Company profile
7.2.2 Representative Pneumococcal Vaccines Product
7.2.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Sanofi
7.3 GSK
7.3.1 Company profile
7.3.2 Representative Pneumococcal Vaccines Product
7.3.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of GSK
7.4 Merck
7.4.1 Company profile
7.4.2 Representative Pneumococcal Vaccines Product
7.4.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Merck
7.5 Eli Lilly
7.5.1 Company profile
7.5.2 Representative Pneumococcal Vaccines Product
7.5.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Eli Lilly
7.6 AstraZeneca
7.6.1 Company profile
7.6.2 Representative Pneumococcal Vaccines Product
7.6.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 Abera
7.7.1 Company profile
7.7.2 Representative Pneumococcal Vaccines Product
7.7.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Abera
7.8 S K Chemicals
7.8.1 Company profile
7.8.2 Representative Pneumococcal Vaccines Product
7.8.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of S K Chemicals
7.9 Beijing Minhai Biotechnology
7.9.1 Company profile
7.9.2 Representative Pneumococcal Vaccines Product
7.9.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Beijing Minhai Biotechnology
7.10 Baxter
7.10.1 Company profile
7.10.2 Representative Pneumococcal Vaccines Product
7.10.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Baxter
7.11 Biken
7.11.1 Company profile
7.11.2 Representative Pneumococcal Vaccines Product
7.11.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Biken
7.12 Celgene Corporation
7.12.1 Company profile
7.12.2 Representative Pneumococcal Vaccines Product
7.12.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Celgene Corporation
7.13 Panacea Biotec
7.13.1 Company profile
7.13.2 Representative Pneumococcal Vaccines Product
7.13.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Panacea Biotec
7.14 Serum Institute of India
7.14.1 Company profile
7.14.2 Representative Pneumococcal Vaccines Product
7.14.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Serum Institute of India
7.15 Genentech
7.15.1 Company profile
7.15.2 Representative Pneumococcal Vaccines Product
7.15.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Genentech
7.16 Genocea Biosciences
7.17 ImmunoBiology
7.18 Lupin
7.19 Nuron Biotech
7.20 Biogen
7.21 Valneva Austria
7.22 Sinovac
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PNEUMOCOCCAL VACCINES
8.1 Industry Chain of Pneumococcal Vaccines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PNEUMOCOCCAL VACCINES
9.1 Cost Structure Analysis of Pneumococcal Vaccines
9.2 Raw Materials Cost Analysis of Pneumococcal Vaccines
9.3 Labor Cost Analysis of Pneumococcal Vaccines
9.4 Manufacturing Expenses Analysis of Pneumococcal Vaccines
CHAPTER 10 MARKETING STATUS ANALYSIS OF PNEUMOCOCCAL VACCINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Pneumococcal Vaccines in This Report
1.2 Commercial Types of Pneumococcal Vaccines
1.2.1 PPSV
1.2.2 PCV 7/13
1.2.3 PCV
1.3 Downstream Application of Pneumococcal Vaccines
1.3.1 For Infants
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (?65)
1.4 Development History of Pneumococcal Vaccines
1.5 Market Status and Trend of Pneumococcal Vaccines 2013-2023
1.5.1 India Pneumococcal Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Pneumococcal Vaccines Market Status and Trend 2013-2023
CHAPTER 2 INDIA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pneumococcal Vaccines in India 2013-2017
2.2 Consumption Market of Pneumococcal Vaccines in India by Regions
2.2.1 Consumption Volume of Pneumococcal Vaccines in India by Regions
2.2.2 Revenue of Pneumococcal Vaccines in India by Regions
2.3 Market Analysis of Pneumococcal Vaccines in India by Regions
2.3.1 Market Analysis of Pneumococcal Vaccines in North India 2013-2017
2.3.2 Market Analysis of Pneumococcal Vaccines in Northeast India 2013-2017
2.3.3 Market Analysis of Pneumococcal Vaccines in East India 2013-2017
2.3.4 Market Analysis of Pneumococcal Vaccines in South India 2013-2017
2.3.5 Market Analysis of Pneumococcal Vaccines in West India 2013-2017
2.4 Market Development Forecast of Pneumococcal Vaccines in India 2017-2023
2.4.1 Market Development Forecast of Pneumococcal Vaccines in India 2017-2023
2.4.2 Market Development Forecast of Pneumococcal Vaccines by Regions 2017-2023
CHAPTER 3 INDIA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole India Market Status by Types
3.1.1 Consumption Volume of Pneumococcal Vaccines in India by Types
3.1.2 Revenue of Pneumococcal Vaccines in India by Types
3.2 India Market Status by Types in Major Countries
3.2.1 Market Status by Types in North India
3.2.2 Market Status by Types in Northeast India
3.2.3 Market Status by Types in East India
3.2.4 Market Status by Types in South India
3.2.5 Market Status by Types in West India
3.3 Market Forecast of Pneumococcal Vaccines in India by Types
CHAPTER 4 INDIA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pneumococcal Vaccines in India by Downstream Industry
4.2 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pneumococcal Vaccines by Downstream Industry in North India
4.2.2 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Northeast India
4.2.3 Demand Volume of Pneumococcal Vaccines by Downstream Industry in East India
4.2.4 Demand Volume of Pneumococcal Vaccines by Downstream Industry in South India
4.2.5 Demand Volume of Pneumococcal Vaccines by Downstream Industry in West India
4.3 Market Forecast of Pneumococcal Vaccines in India by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PNEUMOCOCCAL VACCINES
5.1 India Economy Situation and Trend Overview
5.2 Pneumococcal Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 6 PNEUMOCOCCAL VACCINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN INDIA
6.1 Sales Volume of Pneumococcal Vaccines in India by Major Players
6.2 Revenue of Pneumococcal Vaccines in India by Major Players
6.3 Basic Information of Pneumococcal Vaccines by Major Players
6.3.1 Headquarters Location and Established Time of Pneumococcal Vaccines Major Players
6.3.2 Employees and Revenue Level of Pneumococcal Vaccines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PNEUMOCOCCAL VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pfizer
7.1.1 Company profile
7.1.2 Representative Pneumococcal Vaccines Product
7.1.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Pfizer
7.2 Sanofi
7.2.1 Company profile
7.2.2 Representative Pneumococcal Vaccines Product
7.2.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Sanofi
7.3 GSK
7.3.1 Company profile
7.3.2 Representative Pneumococcal Vaccines Product
7.3.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of GSK
7.4 Merck
7.4.1 Company profile
7.4.2 Representative Pneumococcal Vaccines Product
7.4.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Merck
7.5 Eli Lilly
7.5.1 Company profile
7.5.2 Representative Pneumococcal Vaccines Product
7.5.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Eli Lilly
7.6 AstraZeneca
7.6.1 Company profile
7.6.2 Representative Pneumococcal Vaccines Product
7.6.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 Abera
7.7.1 Company profile
7.7.2 Representative Pneumococcal Vaccines Product
7.7.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Abera
7.8 S K Chemicals
7.8.1 Company profile
7.8.2 Representative Pneumococcal Vaccines Product
7.8.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of S K Chemicals
7.9 Beijing Minhai Biotechnology
7.9.1 Company profile
7.9.2 Representative Pneumococcal Vaccines Product
7.9.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Beijing Minhai Biotechnology
7.10 Baxter
7.10.1 Company profile
7.10.2 Representative Pneumococcal Vaccines Product
7.10.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Baxter
7.11 Biken
7.11.1 Company profile
7.11.2 Representative Pneumococcal Vaccines Product
7.11.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Biken
7.12 Celgene Corporation
7.12.1 Company profile
7.12.2 Representative Pneumococcal Vaccines Product
7.12.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Celgene Corporation
7.13 Panacea Biotec
7.13.1 Company profile
7.13.2 Representative Pneumococcal Vaccines Product
7.13.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Panacea Biotec
7.14 Serum Institute of India
7.14.1 Company profile
7.14.2 Representative Pneumococcal Vaccines Product
7.14.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Serum Institute of India
7.15 Genentech
7.15.1 Company profile
7.15.2 Representative Pneumococcal Vaccines Product
7.15.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Genentech
7.16 Genocea Biosciences
7.17 ImmunoBiology
7.18 Lupin
7.19 Nuron Biotech
7.20 Biogen
7.21 Valneva Austria
7.22 Sinovac
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PNEUMOCOCCAL VACCINES
8.1 Industry Chain of Pneumococcal Vaccines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PNEUMOCOCCAL VACCINES
9.1 Cost Structure Analysis of Pneumococcal Vaccines
9.2 Raw Materials Cost Analysis of Pneumococcal Vaccines
9.3 Labor Cost Analysis of Pneumococcal Vaccines
9.4 Manufacturing Expenses Analysis of Pneumococcal Vaccines
CHAPTER 10 MARKETING STATUS ANALYSIS OF PNEUMOCOCCAL VACCINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
